Skip to content
Buchalter
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Attorneys
  • Practices & Industries
  • Thought Leadership
    • Publications
      • Chemical Law & Prop 65 Blog
    • Webinars
    • Videos
    • Podcasts
  • News & Events
    • News
    • Events/
      Speaking Engagements
  • Payment Portal
    • Pay your invoice
    • Pay your retainer
  • Attorneys
  • Practices & Industries
  • Thought Leadership +
    • Videos
    • Podcasts
    • Publications
    • Chemical Law & Prop 65 Blog
    • Webinars
  • News & Events +
    • News
    • Events/
      Speaking Engagements
  • About
  • Careers
  • Diversity
  • Contact
  • Offices
  • Payment Portal +
    • Pay your invoice
    • Pay your retainer
« View All News

Buchalter Shareholder Frank X. Curci Re-Elected to Cancer Research And Biostatistics’ Board of Directors

July 7, 2025

Frank X. Curci, a Shareholder at the Buchalter law firm in its Portland and Scottsdale offices, was recently re-elected as a Director on the Board of Directors of Cancer Research And Biostatistics (“CRAB”). Curci has been a Director at CRAB since 2012 and serves on the Board’s Strategic Planning Committee.

Frank X. Curci, a Shareholder at the Buchalter law firm in its Portland and Scottsdale offices, was recently re-elected as a Director on the Board of Directors of Cancer Research And Biostatistics (“CRAB”). Curci has been a Director at CRAB since 2012 and serves on the Board’s Strategic Planning Committee.

CRAB is a nonprofit bioscience organization based in Seattle, Washington. CRAB's mission is to help conquer cancer and other diseases by participating in all aspects of the design, conduct, and analysis of clinical trials. Recognized internationally, CRAB provides biostatistical expertise, advanced clinical trial data solutions, and management capabilities to support cancer therapeutic and prevention research.

CRAB also plays a key critical role in clinical collaborations and strategic partnerships with biopharmaceutical companies and research institutions to advance clinical trials and drug development.

“It has been an honor to serve as a Director at CRAB, and I look forward to continuing to assist CRAB with their mission and goals in the coming years while on the CRAB Board,” Curci said.

Curci’s practice focuses on representing companies in the high-technology and bioscience industries, universities, research institutions, and global technology consortia regarding a range of technology, intellectual property, research, data rights/privacy, and corporate/business matters.

In particular, Curci has developed a practice representing research institutions and universities in the Western United States regarding intellectual property licensing, technology transfer, collaborations, and other research matters.

Curci has also developed a practice forming and representing global technology standards-setting consortia in the high technology industry.

Antje Hoering, PhD, the President and CEO of CRAB noted, "Frank’s experience representing other bioscience research institutions, particularly in the area of collaborations, provides a valuable perspective to our Board of Directors. His experience is particularly beneficial given CRAB’s involvement in global clinical trials and partnerships with other scientific institutions.”

As a result of his experience, Curci has been recognized as one of The Best Lawyers in America® from 2009 to 2025 in both the Biotechnology Law and Technology Law fields.

Curci was an Adjunct Professor of Law teaching intellectual property courses at Arizona, California, and Oregon law schools. He has also written and lectured on topics relevant to the bioscience and high technology industries.

Additional Coverage:

Attorney at Law Magazine

AZ Big Media


About Cancer Research And Biostatistics
Cancer Research And Biostatistics (CRAB) is a 501(c) (3) nonprofit bioscience corporation based in Seattle, Washington. CRAB's mission is to help conquer cancer and other diseases by participating in all aspects of the design, conduct, and analysis of clinical trials. Recognized internationally, CRAB provides biostatistical expertise, advanced clinical trial data solutions, and management capabilities to support cancer therapeutic and prevention research. CRAB is also leading efforts in forming research collaborations and strategic partnerships with biopharmaceutical companies and research institutions to advance clinical trials and clinical drug development. For more information about CRAB, visit: www.crab.org.

About Buchalter
Buchalter is a full-service business law firm representing local, regional, national, and international clients in a multitude of practice areas and their subspecialties, among them: Bank and Finance, Corporate, Health Care, Litigation, Insolvency and Financial Law, Intellectual Property, Labor and Employment, Real Estate, and Tax and Estate Planning. Buchalter has approximately 550 attorneys with offices in California, Oregon, Washington, Arizona, Colorado, Utah, Illinois, Georgia, and Tennessee.  For more information about the firm, visit: www.buchalter.com.CRAB is a nonprofit bioscience organization based in Seattle, Washington. CRAB's mission is to help conquer cancer and other diseases by participating in all aspects of the design, conduct, and analysis of clinical trials. Recognized internationally, CRAB provides biostatistical and other clinical trial expertise to support cancer research.

Share

Related Attorneys

  • Frank X. Curci

Adam Bass, Buchalter President & CEO

  • About
  • Careers
  • News & Events
  • Subscribe
  • Atlanta
  • Chicago
  • Denver
  • Los Angeles
  • Napa Valley
  • Nashville
  • Orange County
  • Portland
  • Sacramento
  • Salt Lake City
  • San Diego
  • San Francisco
  • Scottsdale
  • Seattle
  • © Copyright 2025 Buchalter, A Professional Corporation
  • Privacy Notice
  • Notice at Collection
  • Do Not Sell or Share PI
  • Tenrec Logo